Literature DB >> 30635300

Rare diagnosis in a patient with diabetes with nephrotic proteinuria.

Ariana Azevedo1, Patrícia Cotovio1, Mário Góis1, Fernando Nolasco1.   

Abstract

We report a 63-year-old man with well-controlled type 2 diabetes mellitus and hypertension, who presented with new onset nephrotic proteinuria and rapid deterioration in renal function. The atypical clinical presentation prompted us to consider a non-diabetic and non-hypertensive cause and to perform a renal biopsy. A diagnosis of fibrillarglomerulonephritis (FGn) was made based on electronic microscopy. Proteinuria remained in nephrotic range despite treatment with prednisolone, and renal function deteriorated. We suggest that other causes of proteinuria should be considered in patients with diabetes who present with the nephrotic syndrome when there is no other evidence of microvascular disease. We review the spectrum of fibrillar glomerulopathies including FGn, primary and secondary amyloidosis and immunotactoid glomerulonephritis. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  proteinurea; renal intervention

Mesh:

Substances:

Year:  2019        PMID: 30635300      PMCID: PMC6340571          DOI: 10.1136/bcr-2017-223835

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Fibrillary glomerulonephritis and immunotactoid glomerulopathy.

Authors:  Bela Ivanyi; Peter Degrell
Journal:  Nephrol Dial Transplant       Date:  2004-09       Impact factor: 5.992

2.  Fibrillary glomerulonephritis: a report of 66 cases from a single institution.

Authors:  Samih H Nasr; Anthony M Valeri; Lynn D Cornell; Mary E Fidler; Sanjeev Sethi; Nelson Leung; Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

Review 3.  Clinical features, predictors of disease progression and results of renal transplantation in fibrillary/immunotactoid glomerulopathy.

Authors:  P H Pronovost; H R Brady; M E Gunning; O Espinoza; H G Rennke
Journal:  Nephrol Dial Transplant       Date:  1996-05       Impact factor: 5.992

4.  Fibrillary glomerulonephritis in a patient with type 2 diabetes mellitus.

Authors:  G A L Gielen; J F M Wetzels; E J Steenbergen; A H Mudde
Journal:  Neth J Med       Date:  2006-04       Impact factor: 1.422

5.  Fibrillary-immunotactoid glomerulopathy with renal deposits of IgAlambda: a rare cause of glomerulonephritis.

Authors:  E E van Ginneken; K J Assmann; M I Koolen; J L Jansen; J F Wetzels
Journal:  Clin Nephrol       Date:  1999-12       Impact factor: 0.975

Review 6.  The fibrillary glomerulopathies.

Authors:  S M Korbet; M M Schwartz; E J Lewis
Journal:  Am J Kidney Dis       Date:  1994-05       Impact factor: 8.860

7.  Immunotactoid (microtubular) glomerulopathy: an entity distinct from fibrillary glomerulonephritis?

Authors:  C E Alpers
Journal:  Am J Kidney Dis       Date:  1992-02       Impact factor: 8.860

8.  Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the congo red-negative amyloid-like fibrils of fibrillary glomerulopathy.

Authors:  G C Yang; R Nieto; I Stachura; G R Gallo
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

9.  Fibrillary glomerulonephritis and immunotactoid glomerulopathy.

Authors:  Charles E Alpers; Jolanta Kowalewska
Journal:  J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 10.121

10.  Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy.

Authors:  Muhammad M Javaid; Helen Denley; Senyo Tagboto
Journal:  BMC Nephrol       Date:  2007-05-09       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.